发明授权
- 专利标题： MALARIA PRIME/BOOST VACCINES
- 专利标题（中）： 初免 - 加强疫苗恶性疟原虫
-
申请号： EP05808091.2申请日： 2005-10-13
-
公开(公告)号： EP1802336B1公开(公告)日： 2011-09-07
- 发明人: PAU, Maria Grazia , GOUDSMIT, Jaap , COHEN, Joseph D., GlaxoSmithKline , DUBOIS, Patrice M., GlaxoSmithKline , STEWART, V. Ann , HEPPNER, Donald
- 申请人： Crucell Holland B.V. , GlaxoSmithKline Biologicals SA , The Government of the United States, as represen- ted by the Secretary of the Army, on behalf of the Walter Reed Army Institute of Research
- 申请人地址： Archimedesweg 4 2333 CN Leiden NL
- 专利权人： Crucell Holland B.V.,GlaxoSmithKline Biologicals SA,The Government of the United States, as represen- ted by the Secretary of the Army, on behalf of the Walter Reed Army Institute of Research
- 当前专利权人： Crucell Holland B.V.,GlaxoSmithKline Biologicals SA,The Government of the United States, as represen- ted by the Secretary of the Army, on behalf of the Walter Reed Army Institute of Research
- 当前专利权人地址： Archimedesweg 4 2333 CN Leiden NL
- 代理机构： Stephen, Robert John
- 优先权： US619056P 20041014; EP04105035 20041014
- 国际公布： WO2006040334 20060420
- 主分类号： A61K39/015
- IPC分类号： A61K39/015
摘要：
Described are vaccine regimens in which specific prime/boost regimens are applied using low-neutralized recombinant adenoviral vectors harboring nucleic acids encoding antigens from Plasmodium falciparum and purified recombinant protein vaccines such as RTS,S, in the context of appropriate adjuvants.
公开/授权文献
- EP1802336A1 MALARIA PRIME/BOOST VACCINES 公开/授权日：2007-07-04
信息查询
